Bilateral Transversus Abdominis Plane Block Versus Atracurium During Laparoscopic Gynecology Procedures.

• Status: Completed
• Trial end date: 2015-10-31
• Target enrollment: 0
• Participant gender: All

Summary

A monocentric, prospective, randomized controlled trial, including patients proposed for a laparoscopic gynecologic surgery comparing the muscular relaxing effect of a bilateral ultrasound-guided Transversus Abdominis Plane block to usual neuromuscular blockade agent (Atracurium)

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Tunis El Manar
• Treatments: Atracurium; Neuromuscular Blocking Agents

Criteria

Inclusion Criteria:

• American Association of anesthesiologists' class I to III (ASA I to ASA III)

• undergoing laparoscopic gynecologic procedures

Non inclusion Criteria:

• patients' refusal to be part of the study

• ASA IV and higher

• known allergic history to Propofol or any of its components (eggs, soya and beans, etc.), suxamethonium, Fentanyl or Atracurium.

• Patients who presents any regional anesthesia contraindication as clotting disorders, injection site infection and allergy to local anesthetics

• Psychiatric and neurologic disorders and the inability to understand pain scores and the study protocol

Exclusion Criteria:

• unsuccessful TAP block

• Observed anesthesia or surgical incident which requires the end of the ongoing procedure or the conversion to laparotomy